ase report: Artificial thymic organoids facilitate clinical decisions for a patient with a TP63 variant and severe persistent T cell lymphopenia

Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Preview

Gall A, Bosticardo M, Ma S, Chen K, Amini K, Pala F, Delmonte OM, Wenger T, Bamshad M, Sleasman J, Blessing M, van Oers NSC, Notarangelo LD, de la Morena MT. Case report: Artificial thymic organoids facilitate clinical decisions for a patient with a TP63 variant and severe persistent T cell lymphopenia. Front Immunol. 2024 Sep 18;15:1438383. doi: 10.3389/fimmu.2024.1438383. PMID: 39364398; PMCID: PMC11448704.